| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |